Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).
Dr. Yayun Du is an Assistant Professor in the Department of Electrical and Computer Engineering at Vanderbilt University School of Engineering. She holds a Ph.D. in Robotics and System Control (Minor: Solid Mechanics) from UCLA (2022) and was a postdoctoral scholar at Northwestern University's Rogers Group through 2024. Current faculty at Vanderbilt University Ph.D. from University of California, Los Angeles Postdoctoral experience at Northwestern University Her research integrates bioelectronics and robotics through three core directions: 1) Developing multimodal wearable/implantable sensors for health monitoring, 2) Creating human-in-the-loop interaction systems using brain-computer interfaces, and 3) Applying machine learning to medical environment robotics. She has deployed four sensor types across seven hospitals globally, serving users from neonates to elderly patients. Dr. Du's recent publications focus on wireless bioelectronic devices ( PNAS ), sustainable sensor materials ( ACS Sustainable Chemistry & Engineering ), and agricultural robotics ( ICRA , IROS ). She serves as Associate Editor for ICRA 2025 and has received two Best Paper Award final nominations at IROS 2021. Finalist - Best Paper Award in Agri-Robotics (IROS 2021) Finalist - Best Paper Award in Robot Mechanisms and Design (IROS 2021) As head of the Du Group, she leads interdisciplinary research with applications in both healthcare and agricultural contexts, collaborating with Vanderbilt Institute for Surgery and Engineering (VISE) and clinical partners. Her work emphasizes deployable systems that transition from academic research to real-world implementation in medical and industrial environments.
Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.
David J Mehlman, MD serves as an Associate Professor in the Department of Medicine (Cardiology) at Northwestern University's Feinberg School of Medicine, with clinical practice at Northwestern Memorial Hospital. His expertise spans echocardiography, general cardiology, and prosthetic heart valve disease management. His academic training includes: MD from Johns Hopkins University (1973) Internal Medicine Intern at Johns Hopkins Hospital (1974) Medicine Resident at Johns Hopkins Hospital (1976) Cardiology Fellowship at University of Chicago Hospitals (1978) Dr. Mehlman's research focuses on structural heart disease mechanisms and diagnostic applications, particularly in valve prostheses evaluation and exercise-induced cardiac adaptations. His work bridges clinical cardiology with cardiovascular imaging techniques to address complications in valvular interventions and transplant-related cardiomyopathies. His publication history reveals consistent contributions to cardiovascular pathology, with emphasis on aortic homograft performance, amyloidosis-related cardiac deterioration, and athlete physiology. Key methodologies involve advanced echocardiography and radiofrequency ultrasound for prosthetic valve assessment. He maintains prestigious recognition as a Castle Connolly Top Doctor across multiple years: Castle Connolly Top Doctor (2019) Castle Connolly Top Doctor (2018) Castle Connolly Top Doctor (2017) Castle Connolly Top Doctor (2016) Castle Connolly Medical Top Doctor (2006) Castle Connolly Medical Top Doctor (2005) Castle Connolly Medical Top Doctor (2005) Castle Connolly Medical Top Doctor (2004) Board certified in Internal Medicine and Cardiovascular Disease by the American Board of Internal Medicine, Dr. Mehlman integrates clinical practice with ongoing research in structural heart disease while adhering to Northwestern's professional disclosure standards.
Massimo Mischi is a Full Professor at the Faculty of Electrical Engineering of the Eindhoven University of Technology (TU/e) and chairs the Signal Processing Systems (SPS) Division , the largest division at TU/e with over 250 researchers. He founded the Biomedical Diagnostics (BM/d) Lab in 2012, which now includes 180 researchers and clinical/industrial advisors, focusing on biomedical signal processing for diagnostics and monitoring.
Angela Pitenis is an Associate Professor in the Department of Materials at the University of California, Santa Barbara (UCSB), within the College of Engineering. Her research focuses on interfacial phenomena in soft materials, particularly friction, adhesion, wear, and deformation of complex surfaces ranging from living cells to polymer nanocomposites. She employs advanced experimental techniques such as microscopy, spectroscopy, and interferometry to study these interfaces under extreme conditions and within buried environments. Her work has direct applications in healthcare, energy sustainability, and engineering design. Prof. Pitenis holds a Ph.D., M.Sc., and B.S. in Mechanical Engineering from the University of Florida. Her research group investigates biomaterials, hydrogel lubrication, and bioinspired materials, with recent studies addressing implant-associated inflammation, tumor cell dynamics in 3D microgels, and pH-responsive hydrogel friction. She is affiliated with the Materials Research Lab at UCSB and contributes to interdisciplinary projects at the intersection of materials science and biology. Notable research trends in her work include the development of biocompatible lubricious surfaces, understanding friction-induced biological responses, and designing smart materials with tunable mechanical properties. Her studies on photoresponsive hydrogels and superlubricious materials highlight innovations in responsive and adaptive material systems. Pitenis emphasizes in situ experimental methods and has pioneered techniques for analyzing dynamically evolving material interfaces. Her research also extends to marine biomaterials, such as the mechanical resilience of sessile tunicates, and explores applications in medical implants, bioreactors, and energy systems. While specific awards are not listed here, her contributions reflect a commitment to advancing soft matter tribology and biomaterials science.
Professor Shaun Gregory is the Director of the Centre for Biomedical Technologies at Queensland University of Technology (QUT), where he also serves as Co-Director of the Artificial Heart Frontiers Program, Founder and Director of the Heart Hackathon student team competition, and Director of the CardioRespiratory Engineering and Technology Laboratory. He holds appointments in the Faculty of Engineering, School of Mechanical, Medical & Process Engineering. His educational background includes Bachelor, Masters (research), and PhD degrees, all awarded by QUT. He also holds both NHMRC and Heart Foundation fellowships, demonstrating his significant contributions to cardiovascular research. Professor Gregory's research applies a translational approach to cardiovascular engineering with a particular focus on devices used to support or replace the heart. His work brings together multidisciplinary teams of engineering, biomedical science, design, and medicine to develop novel technical solutions for clinically relevant problems. His research has changed clinical practice on numerous occasions and assisted with the regulatory approval of medical devices. His areas of interest include mechanical circulatory support, artificial heart development, cardiovascular device engineering, and hemodynamics. His publication portfolio demonstrates a strong focus on extracorporeal membrane oxygenation (ECMO), ventricular assist devices, and cardiovascular device testing. His recent work has explored computational fluid dynamics in blood flow analysis, novel cannula design for circulatory support, and the hemodynamic effects of various cardiovascular devices. His research often bridges engineering principles with clinical applications, resulting in practical innovations in cardiac support technologies. NHMRC Fellowship Heart Foundation Fellowship President-Elect of the International Society for Mechanical Circulatory Support Professor Gregory has successfully secured more than $65 million in research funding and has published over 100 research articles in his field. He is actively involved in mentoring the next generation of researchers, currently accepting Honours, Masters, and PhD students. His CardioRespiratory Engineering and Technology Laboratory serves as a hub for interdisciplinary research that brings together engineering, biomedical science, and clinical expertise to address critical challenges in cardiovascular medicine.
W. Hong Yeo is a Professor in the Woodruff School of Mechanical Engineering and Program Faculty in Bioengineering at the Georgia Institute of Technology, where he also directs the WISH Center. He holds adjunct appointments in the Wallace H. Coulter Department of Biomedical Engineering. Previously, he was an Assistant Professor at Virginia Commonwealth University (2014-2016) and a postdoctoral fellow at the University of Illinois Urbana-Champaign's Beckman Institute. Dr. Yeo's research integrates nanomechanics, soft materials, and nano-microfabrication to develop bio-interfaced systems. Key areas include: Flexible Bioelectronics : Wearable/implantable sensors for health monitoring Human-Machine Interfaces : Neural prosthetics and soft robotics Translational Nanoengineering : Nanoparticle biosensing and diagnostics His publications (2023-2025) demonstrate strong focus on wireless health technologies, including multi-modal wearable systems, implantable sensors for cardiovascular/neurological monitoring, and AI-integrated diagnostics. Trends show increasing emphasis on closed-loop therapeutic systems and scalable manufacturing. Awards & Recognition : BMES Innovation and Career Development Award Virginia Commercialization Award Blavatnik Award Nominee NSF Summer Institute Fellowship Research funding sources include MEDARVA Foundation, NIH, DARPA, and industry partners like CooperVision. He leads the Center for Human-Centric Interfaces & Engineering , developing next-generation bio-interfaced systems.
David N. Ku is the Lawrence P. Huang Endowed Chair for Engineering Entrepreneurship and Regents' Professor at Georgia Institute of Technology. He holds appointments in the School of Mechanical Engineering (Woodruff School) within the College of Engineering. His research focuses on biofluid mechanics, medical device innovation, and translational technology, with emphasis on thrombosis mechanisms and vascular diseases. Education: M.D. from Emory University (1984); Ph.D. and M.S. from Georgia Tech (1983, 1982); B.A. from Harvard University (1978). Research interests include unsteady fluid dynamics in vascular systems, nanoparticle medical devices for thrombosis prevention, and porous thrombus applications for hemostasis. His work bridges bioengineering with entrepreneurship, teaching product development at the Business School and collaborating with Emory University, Paris Tech-Mines, and ETH Zurich. Key awards include the American Institute for Medical and Biological Engineering Fellowship, DLA Piper Inventor of the Year, and NSF Presidential Young Investigator Award. His research is funded by NIH, NSF, and industry partners. Labs/Teams: Leads a lab using microfluidics and computational mechanics for vascular disease solutions. Collaborates on technologies to address post-partum hemorrhage and traumatic bleeding.
Dr. Darryl Dickerson is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU), part of the College of Engineering. His research focuses on mechanical characterization of biological interfaces, design of bioinspired materials, and advancing inclusive engineering education practices. He holds a Ph.D. (details not explicitly provided in text). Research Interests: Dr. Dickerson’s work bridges biomechanics and biomaterials engineering with social equity in education. Key areas include: Mechanical properties of biological interfaces (e.g., bone-cartilage junctions) Development of biomaterials for tissue repair using 3D printing and electrospinning Anti-marginalization strategies in engineering education, particularly for Black and Brown students Publications Trends: Recent work emphasizes dual themes: (1) Biomedical innovation through advanced material fabrication and (2) Inclusive pedagogy addressing systemic inequities in STEM education. Notable contributions include scaffold designs for osteochondral repair and frameworks for reducing microaggressions in team-based learning. Grants and Advising: No specific grants or advisees listed in the provided text. His work appears to be grant-funded through NIH/National Science Foundation pathways common in biomaterials and education research. Labs and Teams: While not explicitly stated, his research likely involves collaborations with FIU’s Center for Engineering and Computing’s diversity initiatives and biomaterials labs focusing on tissue engineering applications.
Elvin Kedhi, MD, PhD is an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he is affiliated with the Cardiovascular Health Across the Lifespan Program. As a faculty member at McGill University's Faculty of Medicine, he contributes to both clinical practice and academic research in cardiology. Dr. Kedhi's research focuses on interventional cardiology, particularly coronary artery disease management, fractional flow reserve techniques, and clinical trials comparing different treatment approaches for cardiovascular conditions. His work often involves complex clinical scenarios including patients with diabetes, high bleeding risk, and multivessel coronary disease. He has pioneered research on thin-cap fibroatheroma identification and its clinical implications, as well as optimal dual antiplatelet therapy durations following stent implantation. His recent publications demonstrate a strong emphasis on comparing transcatheter and surgical approaches for treating patients with combined aortic valve stenosis and coronary artery disease. Dr. Kedhi frequently collaborates with international research teams across Europe and North America, contributing to large-scale multicenter clinical trials that shape current cardiovascular treatment guidelines. Active researcher in interventional cardiology clinical trials Focus on optimizing treatment strategies for complex coronary artery disease Expertise in fractional flow reserve and intravascular imaging techniques International collaborations across multiple continents Dr. Kedhi maintains an active clinical research program with numerous ongoing studies examining innovative approaches to cardiovascular disease management. His work bridges the gap between technological advances in cardiac interventions and practical clinical applications that improve patient outcomes.
Martin Gosau is a Professor at the Clinic and Polyclinic for Oral and Maxillofacial Surgery within the Medical Faculty of the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on Oral Surgery , Maxillofacial Surgery , and Regenerative Medicine , with a strong emphasis on Dental Implants , Head and Neck Cancer , and Oral Pathology . University: University Medical Center Hamburg-Eppendorf School: Medical Faculty Department: Oral and Maxillofacial Surgery Academic Rank: Professor His recent work explores: Oral Health in Genetic Disorders (e.g., hypophosphatasia) Advanced Surgical Techniques (e.g., nanosecond lasers, fluorescence angiography) Biomaterials and Tissue Engineering (e.g., silk fibroin membranes, extracellular vesicles) Cancer Prognostics (e.g., DCBLD1 overexpression in HNSCC) Key trends in his 15 most recent articles include applications of machine learning in oral diagnostics, stem cell research for bone regeneration, and biomaterials in reconstructive surgery. He frequently collaborates with Ralf Smeets and Thomas Vollkommer , with publications spanning Frontiers in Immunology , Oral Surgery , and Scientific Reports .
Dr. Parth Chansoria is a Lecturer at the Department of Health Sciences and Technology at ETH Zürich, where he leads biofabrication research within the Tissue Engineering and Biofabrication (TEB) group. His work focuses on structured light technology for regenerative medicine applications, including in vivo bioprinting and microgravity-based tissue engineering. He holds Ambizione and Spark grants from the Swiss National Science Foundation and has pioneered innovations in light-guided biofabrication, collagen-based resins, and anisotropic tissue design. Research domains include: Filamented light biofabrication for aligned tissues Minimally invasive light-based in vivo bioprinting Musculoskeletal tissue engineering in microgravity Isotonic collagen-based photocrosslinkable resins He has secured over 6 patents and received prestigious awards including the ISBF Early Career Investigator Award (2022), Marie Curie Actions Fellowship (2021), and SME 30 Under 30 recognition (2021). His interdisciplinary research bridges bioengineering, materials science, and clinical applications. Key collaborations include projects at UNC Chapel Hill (USA) and NC State (USA), where he developed biomimetic patches for dynamic organ pathologies and ultrasound-assisted cell patterning. His lab explores novel bioinks, hybrid fabrication techniques, and translational applications in regenerative medicine.
Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.
